Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 5Phase 4 5Phase 1/2 3

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 4

Conditions

Keratosis, Actinic 3Skin Diseases 1Connective Tissue Diseases 1Carcinoma, Basal Cell 1Bowen's Disease 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Interventional × methyl 5-aminolevulinate × Clear all
NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed
250 enrolled

Bowen's Disease

NCT03511326 2021-02-18

SESAME 2

Galderma R&D

Phase 4 Completed
50 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT02464709 2019-08-28

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Joint Authority for Päijät-Häme Social and Health Care

Phase 4 Completed
72 enrolled
Dermatologic

Keratosis, Actinic

NCT01538901 2017-09-12

AKtransplant

Medical University of Vienna

Phase 4 Terminated
10 enrolled
Dermatologic

Keratosis, Actinic

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Maastricht University Medical Center

Phase 4 Unknown
162 enrolled
Dermatologic

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡